Gene · 4241
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simulated Solute Tempering 2: An Efficient and Practical Approach to Protein Conformational Sampling and Binding Events. | J Chem Theory Comput | 2025 | 41139839 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes for lung adenocarcinoma prognosis based on PANoptosis-related genes. | Discov Oncol | 2025 | 41117866 | PubTator, text mining | PubMed |
| Cryo-EM structure of the human Derlin-1/p97 complex reveals a hexameric channel in ERAD. | Commun Biol | 2025 | 41107410 | PubTator, text mining | PubMed |
| Associations of 2923 Olink proteins with demographic, lifestyle, environmental and health characteristics in middle-aged Chinese adults. | Eur J Epidemiol | 2025 | 41071435 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer. | Cancer Med | 2025 | 40970572 | PubTator, text mining | PubMed |
| A bottomless well: 1,2,4-Triazoles continue to inspire scientific researchers to develop more and more anticancer molecules. | Bioorg Med Chem | 2025 | 40957262 | PubTator, text mining | PubMed |
| Unraveling cooperative and competitive interactions within protein triplets in the human interactome. | Sci Rep | 2025 | 40954205 | PubTator, text mining | PubMed |
| A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni. | Proc Natl Acad Sci U S A | 2025 | 40880532 | PubTator, text mining | PubMed |
| Substrate structure determines p97- and RAD23A/B-mediated proteasomal degradation in human cells. | J Biochem | 2025 | 40795920 | PubTator, text mining | PubMed |
| Redox mechanism of glycerophospholipids and relevant targeted therapy in ferroptosis. | Cell Death Discov | 2025 | 40744916 | PubTator, text mining | PubMed |
| ATP-competitive inhibitors for cancer treatment - kinases and the world beyond. | RSC Med Chem | 2025 | 40612269 | PubTator, text mining | PubMed |
| Single-Molecule Force Spectroscopy Reveals the Mechanical Role of p47 in Protein Stabilization. | Biochemistry | 2025 | 40555673 | PubTator, text mining | PubMed |
| Small Molecule-Induced Alterations of Protein Polyubiquitination Revealed by Mass-Spectrometric Ubiquitome Analysis. | Angew Chem Int Ed Engl | 2025 | 40444580 | PubTator, text mining | PubMed |
| Genome-wide approach to study gene-nutrient intake interactions in type 2 diabetes mellitus in a large Korean cohort. | Front Nutr | 2025 | 40400704 | PubTator, text mining | PubMed |
| Molecular Tweezers Block the Functional Pore of a Protein Machine. | J Am Chem Soc | 2025 | 40354241 | PubTator, text mining | PubMed |
| SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast Cancer. | Cancer Med | 2025 | 40326388 | PubTator, text mining | PubMed |
| Liposome-Polymer Nanoparticles Loaded with Copper Diethyldithiocarbamate and 6-Bromo-Indirubin-3'-Oxime Enable the Treatment of Refractive Melanoma. | Small | 2025 | 40317886 | PubTator, text mining | PubMed |
| Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networks. | Nat Chem Biol | 2025 | 40246979 | PubTator, text mining | PubMed |
| PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways. | J Cell Biol | 2025 | 40239066 | PubTator, text mining | PubMed |
| NUB1 traps unfolded FAT10 for ubiquitin-independent degradation by the 26S proteasome. | Nat Struct Mol Biol | 2025 | 40217121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4241/papers?page=2